Lincoln Alternative Strategies LLC - Sep 12, 2025 SCHEDULE 13G Report for Silexion Therapeutics Corp. Ordinary Shares, par value $0.0009 per share (SLXN)

Filing Manager: Lincoln Alternative Strategies LLC
Reporting Manager: Lincoln Alternative Strategies LLC
Security: Silexion Therapeutics Corp. Ordinary Shares, par value $0.0009 per share
Symbol: SLXN
Shares outstanding: 2.12M shares
Disclosed Ownership: 131K shares
Ownership: 6.18%
Form type: SCHEDULE 13G
Date filed: 9/15/2025, 12:31 PM
Date of event: Sep 12, 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Lincoln Alternative Strategies LLC	6.18%	131K	131K	0	/s/ Stephen Temes	Stephen Temes/Managing Member